Shuang Xiang

Title: Shuang Xiang: Innovator in Primary Amines Synthesis

Introduction

Shuang Xiang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of chemistry, particularly in the synthesis of primary amines. His innovative methods have the potential to impact various industries, including pharmaceuticals and materials science.

Latest Patents

Shuang Xiang holds a patent for a method for efficiently synthesizing primary amines. This method utilizes carbonyl compounds or alcohol compounds as reaction substrates, with liquid ammonia or alcohol solutions of ammonia serving as the nitrogen source. Hydrogen is used as the hydrogen source, and the reaction occurs in a medium catalyzed by a cobalt-based catalyst. This approach allows for the reductive amination of carbonyl compounds and the hydrogen-borrowing amination of alcohol compounds at low temperatures, resulting in high yields of primary amines. The primary amines produced can be valuable raw materials for producing polymers, medicines, dyes, and surfactants. The cobalt-based catalyst not only demonstrates high catalytic activity but also has good industrial application prospects due to its magnetic properties, which facilitate separation and recycling. Additionally, the use of an inexpensive cobalt-based catalyst can significantly reduce industrialization costs.

Career Highlights

Shuang Xiang is affiliated with the East China University of Science and Technology, where he continues to advance his research and innovation in chemistry. His work has garnered attention for its practical applications and efficiency.

Collaborations

Shuang Xiang collaborates with esteemed colleagues, including Yanqin Wang and Wanjun Guo, who contribute to his research endeavors.

Conclusion

Shuang Xiang's innovative methods for synthesizing primary amines represent a significant advancement in chemical synthesis. His work not only enhances the efficiency of producing valuable compounds but also holds promise for various industrial applications.